RYLSX
Price
$89.96
Change
+$0.22 (+0.25%)
Updated
Dec 12 closing price
Net Assets
5.84M
VCDAX
Price
$206.51
Change
+$0.35 (+0.17%)
Updated
Dec 12 closing price
Net Assets
6.94B
Interact to see
Advertisement

RYLSX vs VCDAX

Header iconRYLSX vs VCDAX Comparison
Open Charts RYLSX vs VCDAXBanner chart's image
Rydex Leisure A
Price$89.96
Change+$0.22 (+0.25%)
VolumeN/A
Net Assets5.84M
Vanguard Consumer Discretionary Idx Adm
Price$206.51
Change+$0.35 (+0.17%)
VolumeN/A
Net Assets6.94B
RYLSX vs VCDAX Comparison Chart in %
View a ticker or compare two or three
VS
RYLSX vs. VCDAX commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLSX is a Buy and VCDAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCDAX has more cash in the bank: 6.94B vs. RYLSX (5.85M). VCDAX pays higher dividends than RYLSX: VCDAX (0.72) vs RYLSX (0.46). RYLSX was incepted earlier than VCDAX: RYLSX (21 years) vs VCDAX (20 years). RYLSX (1.69) is less costly to investors than VCDAX (0.09). RYLSX is a more actively managed with annual turnover of: 263.00 vs. VCDAX (6.00). RYLSX has a lower initial minimum investment than VCDAX: RYLSX (2500) vs VCDAX (100000). RYLSX annual gain was more profitable for investors over the last year : 2.66 vs. VCDAX (0.16). VCDAX return over 5 years is better than : 51.78 vs. RYLSX (9.57).
RYLSXVCDAXRYLSX / VCDAX
Total Expense Ratio1.640.091,822%
Annual Report Gross Expense Ratio1.690.091,878%
Fund Existence21 years20 years-
Gain YTD8.4476.033140%
Front Load5%N/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRA1000N/A-
Net Assets5.85M6.94B0%
Annual Yield % from dividends0.460.7263%
Returns for 1 year2.660.161,708%
Returns for 3 years45.5969.3866%
Returns for 5 years9.5751.7818%
Returns for 10 years71.37230.7831%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWMIX59.680.65
+1.10%
Hotchkis & Wiley Mid-Cap Value I
LVOPX17.690.12
+0.68%
Lord Abbett Value Opportunities P
FACDX63.97N/A
N/A
Fidelity Advisor Health Care A
MEGBX137.90-0.07
-0.05%
MFS Growth B
TIAGX14.92-0.39
-2.55%
Timothy Plan Small/Mid Cap Growth Cl I